Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
A generative AI model for accurate reconstruction of retinal blood flow from static OCT scans
Author Affiliations & Notes
  • Berkin Durmus
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
  • Oren Avram
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
  • Giulia Corradetti
    Doheny Eye Institute Doheny Image Reading Center, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Sriram Sankararaman
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
  • Srinivas R. Sadda
    Doheny Eye Institute Doheny Image Reading Center, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Eran Halperin
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
  • Jeffrey N. Chiang
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Berkin Durmus None; Oren Avram None; Giulia Corradetti None; Sriram Sankararaman None; Srinivas R. Sadda 4DMT, Abbvie, Alexion, Allergan Inc., Alnylam Pharmaceuticals, Amgen Inc., Apellis Pharmaceuticals, Inc., Astellas, Bayer Healthcare Pharmaceuticals, Biogen MA Inc., Boehringer Ingelheim, Carl Zeiss Meditec, Catalyst Pharmaceuticals Inc., Centervue Inc., GENENTECH, Gyroscope Therapeutics, Heidelberg Engineering, Hoffman La Roche, Ltd., Iveric Bio, Janssen Pharmaceuticals Inc., Nanoscope, Notal Vision Inc., Novartis Pharma AG, Optos Inc., Oxurion/Thrombogenics, Oyster Point Pharma, Regeneron Pharmaceuticals Inc., Samsung Bioepis, Topcon Medical Systems Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Heidelberg Engineering, Optos Inc., Nidek, Topcon, Centervue, Code F (Financial Support), Carl Zeiss Meditec, Heidelberg Engineering, Nidek Incorporated, Novartis Pharma AG, Topcon Medical Systems Inc., Code R (Recipient); Eran Halperin Optum, Code E (Employment); Jeffrey Chiang None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3435. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Berkin Durmus, Oren Avram, Giulia Corradetti, Sriram Sankararaman, Srinivas R. Sadda, Eran Halperin, Jeffrey N. Chiang; A generative AI model for accurate reconstruction of retinal blood flow from static OCT scans. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3435.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A newly developed optical coherence tomography (OCT) modality, called OCT Angiography (OCT-A) allows noninvasive visualization of underlying blood flow and vasculature. It currently drives advances in the understanding of prevalent chronic retinal diseases, such as age-related macular degeneration (AMD). However, this technology is not available in all clinics and even when it is available, relative to standard (static) OCT imaging, the acquisition process of OCT-A is time consuming and prone to signal quality issues, making OCT-A currently ill-suited to the clinic.

Methods : In this work, we develop an AI-based generative model for reconstructing OCT-A representations using standard OCT scans. We also introduce local contrast regularization for the loss function used during training, which enhances the overall performance of our model. Using 500 standard OCT scans acquired from independent patients, we compared our model's ability to infer 2D OCT-A scans for the superficial and choriocapillaris (CC) layers. The layer reconstruction performance was measured by three commonly used metrics: Mean Absolute Error (MAE), Structural Similarity Index Measure (SSIM), and Flow Deficit Error (FDE).

Results : We demonstrate that our proposed method is able to generate superficial and CC OCT-A en face slabs at a higher quality compared to competing methods. Our proposed model outperformed state-of-the-art (SoTA) AI models significantly in SSIM, MAE, and FDE scores, with improvements of 0.25, 0.05, and 0.08, respectively. Moreover, previous studies showed that Flow Deficit (FD) is correlated with age. We found that the CC FD values calculated from the reconstructed images are indeed significantly correlated with age (R2=0.39; p-value<0.05) corroborating our model’s soundness.

Conclusions :
Our framework surpasses current SoTA methods, generating superior superficial and CC OCT-A en face slabs from standard OCT scans for CC FD assessment. This approach promotes clinical research as it allows the regeneration of choriocapillaris OCT-A en face slabs from historical (standard OCT) datasets for which OCT-A was not captured. Moreover, it eliminates the complex and expensive OCT-A acquisition process, which in turn, will enhance diagnostic efficiency and accessibility in clinical settings, representing a notable advancement for the ophthalmology field.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×